FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

36043611000001106: Hydroxyzine 25mg tablets (Medreich Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111169001000001114 Hydroxyzine 25mg tablets (Medreich Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111169101000001110 Hydroxyzine 25mg tablets (Medreich Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxyzine 25mg tablets (Medreich Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Is a Product containing precisely hydroxyzine hydrochloride 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Has basis of strength substance Hydroxyzine hydrochloride true Inferred relationship Existential restriction modifier 1
Hydroxyzine 25mg tablets (Medreich Plc) Has presentation strength numerator value 25 false Inferred relationship Existential restriction modifier 1
Hydroxyzine 25mg tablets (Medreich Plc) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Hydroxyzine 25mg tablets (Medreich Plc) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Hydroxyzine 25mg tablets (Medreich Plc) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Hydroxyzine 25mg tablets (Medreich Plc) Has precise active ingredient Hydroxyzine hydrochloride true Inferred relationship Existential restriction modifier 1
Hydroxyzine 25mg tablets (Medreich Plc) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Has specific active ingredient Hydroxyzine hydrochloride true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Hydroxyzine 25mg tablets (Medreich Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hydroxyzine 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has AMP True Hydroxyzine 25mg tablets (Medreich Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start